Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · EPIGRAL

EPIGRAL

CommoditiesChemicals & Petrochemicals₹4065 cr market cap
₹945.10 ▲ +0.08% today As of 19 Nov 2026
52-week low ₹810.4552-week high ₹1531.00

-38.3% from the 52-week high · +16.5% above the low

Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 872 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The company is also engaged in the Trading of Agrochemical products. The firm manufactures a range of products: caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.

The short version. EPIGRAL reported revenue of ₹746 crore for Sep 2026, up 27.1% from a year earlier. Net profit was ₹65 crore (up 27.5% year on year). Return on equity was 14.9% in Mar 2026. Promoter holding was 68.83% in Sep 2026, down 0.11 points over 8 quarters.

1 · The price

How has the stock traded?

EPIGRAL trades 38.3% below its 52-week high and 16.5% above its 52-week low.

Change over period: —

1M-3.7%
3M-12.7%
6M-23.9%
1Y-36.3%

2 · The business

Is it growing?

Sales, year on year+27.1%

Sep 2026 revenue of ₹746 cr.

Profit, year on year+27.5%

Sep 2026 net profit of ₹65 cr.

Net margin8.7%

Unchanged from a year earlier.

3-year growth-2.1% profit

Revenue compounded at 5.0% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue746705736597587607628645
Net profit6510081395116187104
Net margin %8.714.111.06.58.726.513.816.1
EPS (₹)15.0923.1218.769.0711.8737.2520.1424.02

Annual

FY2026FY2025FY2024FY2023FY2022
Revenue25272550192921881551
Net profit332358196353253
Net margin %13.114.010.216.116.3
EPS (₹)76.9582.9147.1385.0360.84

3 · The quality

How well does it turn capital into profit?

Return on equity was 14.9% in Mar 2026; debt to equity is 0.25.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %14.918.815.633.1
Return on capital %14.822.318.133.0
EBITDA margin %22.928.325.231.7
Net margin %13.113.910.116.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR5.0%—
Profit CAGR-2.1%—
Debt to equity0.25
Interest cover5.8x
Current ratio1.16
P/E ratio14.4

4 · The owners

Who holds it, and are they adding?

Promoter holding68.83%

Down 0.11 pts over 8 quarters.

Foreign institutions0.99%

Down 2.02 pts over 8 quarters.

Domestic institutions4.9%

Up 0.59 pts over 8 quarters.

Mutual fund schemes7

+2 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter68.9468.9568.8368.8368.8368.8368.8368.83-0.11
FII3.013.013.052.712.361.541.030.99-2.02
DII4.314.664.794.925.134.95.564.9+0.59
Public23.7223.3523.3123.5223.6624.724.5525.26+1.54

Mutual fund holdings · Oct 2026

7 schemes hold this stock

5 the month before.

  • Bandhan Business Cycle Fund0.58% of NAV
  • Bandhan Small Cap Fund0.36% of NAV
  • HSBC Value Fund0.3% of NAV
  • HSBC Multi Cap Fund0.14% of NAV
  • Motilal Oswal BSE 1000 Index Fund0.01% of NAV
  • ADITYA BIRLA SUN LIFE BSE TOTAL MARKET ETF0.01% of NAV
  • ADITYA BIRLA SUN LIFE BSE TOTAL MARKET INDEX FUND0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for EPIGRAL are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about EPIGRAL

What is the EPIGRAL share price?

EPIGRAL (EPIGRAL) last closed at ₹945.10, up 0.08% on the day. Its 52-week range is ₹810.45 to ₹1,531.00.

What is the market cap of EPIGRAL?

EPIGRAL has a market capitalisation of about ₹4,065 crore. Its price-to-earnings ratio is 14.4.

How are EPIGRAL's latest results?

EPIGRAL reported revenue of ₹746 crore for Sep 2026, up 27.1% from a year earlier. Net profit was ₹65 crore (up 27.5% year on year). Return on equity was 14.9% in Mar 2026. Promoter holding was 68.83% in Sep 2026, down 0.11 points over 8 quarters.

Who owns EPIGRAL?

As of Sep 2026, shareholding was: Promoter 68.83%, FII 0.99%, DII 4.9%, Public 25.26%.

How many mutual funds hold EPIGRAL?

7 mutual fund schemes held EPIGRAL in October 2026. That compares with 5 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 01 Jun 2026 · Final Dividend - Rs. 5
  • 20 Jun 2025 · Final Dividend - Rs. 3.5
  • 07 Feb 2025 · Interim Dividend - Rs. 2.5
  • 02 Jul 2024 · Final Dividend - Rs. 5
  • 20 Jun 2023 · Final Dividend - Rs. 2.5
  • 01 Feb 2023 · Interim Dividend - Rs. 2.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.